| scholarly article | Q13442814 |
| P50 | author | Sotirios Tsimikas | Q80167861 |
| P2093 | author name string | Yury I Miller | |
| P2860 | cites work | Lipoprotein(a) as a cardiovascular risk factor: current status | Q24623225 |
| Oxidation-specific epitopes and immunological responses: Translational biotheranostic implications for atherosclerosis | Q26822962 | ||
| The danger model: a renewed sense of self | Q28214633 | ||
| Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity | Q29617216 | ||
| Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo | Q30700059 | ||
| The haptoglobin 2-2 genotype is associated with increased redox active hemoglobin derived iron in the atherosclerotic plaque | Q33695531 | ||
| Naturally occurring human plasminogen, like genetically related apolipoprotein(a), contains oxidized phosphatidylcholine adducts | Q33886478 | ||
| Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress | Q34346809 | ||
| A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma | Q34656639 | ||
| Targeted iron oxide particles for in vivo magnetic resonance detection of atherosclerotic lesions with antibodies directed to oxidation-specific epitopes. | Q34982799 | ||
| Innate and acquired immunity in atherogenesis | Q34986341 | ||
| Relationship of IgG and IgM autoantibodies and immune complexes to oxidized LDL with markers of oxidation and inflammation and cardiovascular events: results from the EPIC-Norfolk Study | Q35212898 | ||
| In vivo visualization and attenuation of oxidized lipid accumulation in hypercholesterolemic zebrafish | Q35578606 | ||
| Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events | Q35592510 | ||
| Oxidized phospholipids are present on plasminogen, affect fibrinolysis, and increase following acute myocardial infarction | Q35905628 | ||
| In vivo detection of oxidation-specific epitopes in atherosclerotic lesions using biocompatible manganese molecular magnetic imaging probes | Q35905632 | ||
| Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions | Q36387263 | ||
| Adaptive immunity in atherogenesis: new insights and therapeutic approaches | Q36497196 | ||
| Complement factor H binds malondialdehyde epitopes and protects from oxidative stress | Q36783745 | ||
| Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome | Q36925959 | ||
| Oxidation-specific biomarkers and risk of peripheral artery disease | Q37131142 | ||
| Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans | Q37170775 | ||
| Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice | Q37385727 | ||
| Relationship of oxidized phospholipids on apolipoprotein B-100 particles to race/ethnicity, apolipoprotein(a) isoform size, and cardiovascular risk factors: results from the Dallas Heart Study | Q37434626 | ||
| Lipoprotein modification and macrophage uptake: role of pathologic cholesterol transport in atherogenesis | Q37705133 | ||
| Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity | Q37830940 | ||
| Oxidized low-density lipoprotein as a biomarker of in vivo oxidative stress: from atherosclerosis to periodontitis | Q38026551 | ||
| Emerging therapeutic agents to lower lipoprotein (a) levels | Q38049987 | ||
| Oxidation-specific biomarkers, prospective 15-year cardiovascular and stroke outcomes, and net reclassification of cardiovascular events | Q39526094 | ||
| Human oxidation-specific antibodies reduce foam cell formation and atherosclerosis progression | Q39601696 | ||
| Aged garlic extract supplemented with B vitamins, folic acid and L-arginine retards the progression of subclinical atherosclerosis: a randomized clinical trial | Q39891810 | ||
| The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans | Q40099159 | ||
| Lysine-phosphatidylcholine adducts in kringle V impart unique immunological and potential pro-inflammatory properties to human apolipoprotein(a). | Q40626559 | ||
| Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes | Q41370572 | ||
| Oxidation-specific biomarkers, lipoprotein(a), and risk of fatal and nonfatal coronary events | Q42912066 | ||
| Antisense oligonucleotide lowers plasma levels of apolipoprotein (a) and lipoprotein (a) in transgenic mice | Q43922953 | ||
| Reduced in vivo aortic uptake of radiolabeled oxidation-specific antibodies reflects changes in plaque composition consistent with plaque stabilization | Q45140753 | ||
| Increased plasma oxidized phospholipid:apolipoprotein B-100 ratio with concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering: a potential biomarker of early atherosclerosis regression. | Q45991963 | ||
| Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events | Q46125332 | ||
| Lipid lowering reduces oxidative stress and endothelial cell activation in rabbit atheroma | Q46200093 | ||
| Relation of oxidative biomarkers, vascular dysfunction, and progression of coronary artery calcium | Q46623191 | ||
| Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(-/-)/low-density lipoprotein receptor(-/-) mice | Q46859383 | ||
| Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice | Q46874178 | ||
| Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. | Q54412663 | ||
| Increased Expression of Oxidation-Specific Epitopes and Apoptosis Are Associated With Haptoglobin Genotype | Q61270643 | ||
| P433 | issue | 5 | |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 426-437 | |
| P577 | publication date | 2013-10-01 | |
| P1433 | published in | Current Opinion in Lipidology | Q15758705 |
| P1476 | title | Oxidation-specific epitopes as targets for biotheranostic applications in humans: biomarkers, molecular imaging and therapeutics | |
| P478 | volume | 24 |
| Q28394148 | "Eat me" imaging and therapy |
| Q36669011 | Autoimmune response to transthyretin in juvenile idiopathic arthritis |
| Q39033338 | Context-Dependent Role of Oxidized Lipids and Lipoproteins in Inflammation |
| Q97643655 | IL-10 attenuates OxPCs-mediated lipid metabolic responses in ischemia reperfusion injury |
| Q34518372 | Imaging of oxidation-specific epitopes with targeted nanoparticles to detect high-risk atherosclerotic lesions: progress and future directions |
| Q36887827 | Ins and Outs in Environmental and Occupational Safety Studies of Asthma and Engineered Nanomaterials |
| Q43188537 | Lipoprotein(a) hyperlipidemia as cardiovascular risk factor: pathophysiological aspects |
| Q37680316 | Low acylation stimulating protein levels are associated with cardiometabolic disorders-secondary to autoimmune activation? |
| Q38846881 | Malondialdehyde Epitopes as Targets of Immunity and the Implications for Atherosclerosis |
| Q38389141 | Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans |
| Q38883470 | Oxidized cholesteryl esters and inflammation |
| Q92753286 | Proinflammatory Action of a New Electronegative Low-Density Lipoprotein Epitope |
| Q37682418 | Senescent cells expose and secrete an oxidized form of membrane-bound vimentin as revealed by a natural polyreactive antibody |
Search more.